North America Omega 3 Prescription Drugs Market Size & Outlook
The omega 3 prescription drugs market in North America is expected to reach a projected revenue of US$ 747.7 million by 2030. A compound annual growth rate of 4.3% is expected of North America omega 3 prescription drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$580.0
Forecast, 2030 (US$M)
$747.7
CAGR, 2025 - 2030
4.3%
Report Coverage
North America
North America omega 3 prescription drugs market, 2018-2030 (US$M)
Related Markets
North America omega 3 prescription drugs market highlights
- The North America omega 3 prescription drugs market generated a revenue of USD 580.0 million in 2024.
- The market is expected to grow at a CAGR of 4.3% from 2025 to 2030.
- In terms of segment, lovaza was the largest revenue generating drug in 2024.
- Lovaza is the most lucrative drug segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 580.0 million |
| Market revenue in 2030 | USD 747.7 million |
| Growth rate | 4.3% (CAGR from 2025 to 2030) |
| Largest segment | Lovaza |
| Fastest growing segment | Lovaza |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vascepa, Lovaza |
| Key market players worldwide | Woodward Pharma Services, Mankind Pharma, CSPC Pharmaceutical Group Ltd, Sofgen Pharmaceuticals, Wilshire Pharmaceuticals, Sun Pharmaceutical Industries, PuraCap Pharmaceutical, Chartwell Pharmaceuticals, Amneal Pharmaceuticals Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, North America region accounted for 42.9% of the global omega 3 prescription drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 432.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Omega 3 Prescription Drugs Market Scope
Omega 3 prescription drugs market segmentation & scope
Omega 3 Prescription Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America omega 3 prescription drugs market size, by country, 2018-2030 (US$M)
North America Omega 3 Prescription Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
